Technical Analysis for HIK - Hikma Pharmaceuticals Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | -2.49% | |
| Narrow Range Bar | Range Contraction | -2.49% | |
| Oversold Stochastic | Weakness | -2.49% | |
| 180 Bearish Setup | Bearish Swing Setup | -2.27% | |
| Slingshot Bearish | Bearish Swing Setup | -2.27% | |
| Stochastic Buy Signal | Bullish | -2.27% | |
| Cup with Handle | Other | -2.27% | |
| Lower Bollinger Band Walk | Weakness | -2.27% | |
| Oversold Stochastic | Weakness | -2.27% | |
| Bullish Engulfing | Bullish | -3.03% |
| Alert | Time |
|---|---|
| Down 1 ATR | about 1 hour ago |
| Down 2% | about 1 hour ago |
| Fell Below Lower Bollinger Band | about 1 hour ago |
| Fell Below Previous Day's Low | about 5 hours ago |
| Down 1% | about 5 hours ago |
Get this analysis on your stocks daily!
Hikma Pharmaceuticals Plc Description
Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company develops, manufactures and markets a range of branded and non-branded generic pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms, across the United States, the Middle East and North Africa (MENA) region and Europe. The Company's segments include Branded, Injectables, Generics and Others. The Branded business sells branded generics and in-licensed products across the MENA region and other markets. The Injectables business sells specialized generic injectable products across the globe. The Generics business sells non-injectable generic products in the United States. The Branded business has approximately 380 products in over 1,120 dosage forms and strengths. Its products include Amoclan, Blopress, Omnicef, Prograf and Suprax. The Injectables business' products include Argatroban, Fentanyl, Glycopyrrolate, Nicardipine and Phenylephrine.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmaceuticals Strength Pharmaceutical Products Supra Pharmaceutical Companies Dosage Forms North Africa
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2221.4639 |
| 52 Week Low | 1710.5872 |
| Average Volume | 405,273 |
| 200-Day Moving Average | 1938.06 |
| 50-Day Moving Average | 1910.74 |
| 20-Day Moving Average | 1863.93 |
| 10-Day Moving Average | 1835.40 |
| Average True Range | 41.43 |
| RSI (14) | 40.48 |
| ADX | 19.56 |
| +DI | 17.91 |
| -DI | 32.10 |
| Chandelier Exit (Long, 3 ATRs) | 1838.24 |
| Chandelier Exit (Short, 3 ATRs) | 1896.29 |
| Upper Bollinger Bands | 1946.94 |
| Lower Bollinger Band | 1780.93 |
| Percent B (%b) | 0.16 |
| BandWidth | 8.91 |
| MACD Line | -28.30 |
| MACD Signal Line | -21.87 |
| MACD Histogram | -6.4262 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1834.00 | ||||
| Resistance 3 (R3) | 1833.33 | 1823.67 | 1829.50 | ||
| Resistance 2 (R2) | 1823.67 | 1816.79 | 1824.00 | 1828.00 | |
| Resistance 1 (R1) | 1815.33 | 1812.54 | 1819.50 | 1816.00 | 1826.50 |
| Pivot Point | 1805.67 | 1805.67 | 1807.75 | 1806.00 | 1805.67 |
| Support 1 (S1) | 1797.33 | 1798.79 | 1801.50 | 1798.00 | 1787.50 |
| Support 2 (S2) | 1787.67 | 1794.54 | 1788.00 | 1786.00 | |
| Support 3 (S3) | 1779.33 | 1787.67 | 1784.50 | ||
| Support 4 (S4) | 1780.00 |
